Medical Health & Life Science Research News

The US' rosacea market size, trends & forecasts 2018-2022 available in new report

Medical Market Research

The analysis includes rosacea market in terms of value, number of patients; number of patients seeking treatment and market share by segments. It also provides analysis of the US dermatology drugs market in terms of value and market share by segments.

Research By Markets adds "The US Rosacea Market: Size, Trends & Forecasts (20018-2022)" to its online repository. The report provides a detailed analysis of the US Rosacea Market with market sizing and growth pattern.


More information: www.researchbymarkets.com/report/t…18-2022-6297.html Make an Inquiry about this news

Foamix Pharmaceuticals Ltd., Bayer Group, Galderma and Valeant Pharmaceuticals International are some of the major players whose company profiling has been done in the report. This segment of the report summarizes business overview, financial overview and the business strategies adopted by respective companies.

Access full report: www.researchbymarkets.com/6297 Make an Inquiry about this news

Company Coverage

Foamix Pharmaceuticals Ltd.
Bayer Group
Galderma
Valeant Pharmaceuticals International

Executive Summary

Rosacea is a common chronic condition of the skin with a high prevalence rate among the US population. It is observed that it naturally begins at any time after the age of 30 and more and mostly affect the area of nose, cheeks and forehead.

In some cases, rosacea may also occur on the neck, chest, scalp or ears. Rosacea symptoms and signs include facial flushing, fine red vascular lines, swollen, red eyelids and many more.

The disease is more common in women and those who have fair skin. The cause of such skin condition is still unknown and cannot be cured.

The only way to control rosacea is by minimizing its symptoms.

The US rosacea market has grown over the past few years and is anticipated to grow during the forecasted period also i.e. 2018-2022 at a high growth rate on the back of rising incidence rate of the disease among the US population.

The growth in the market will be driven by aging population, unhealthy eating habits and environmental factors, rising disposable income and entry of new drugs and treatments in the market. Yet the market growth is restrained by factors such as lack of awareness and knowledge and stringent government regulations for the approval of new drugs.

News From

Research By MarketsResearch By Markets
Category: Market Research Publishers and RetailersCompany about: Research by Markets is an online Market Research Report Repository. Our repository contains reports segmented by Geography and Industry. We cover all major Industry Verticals - Information Technology, Semiconductor, Electronics, Manufacturing, Food & Beverages, Telecommunications, Healthcare, Pharmaceutical, Automotive, BioTechnology, Energy & Power, Banking and many more. We have dedicated Account Managers for Corporate Clients to ensure seamless customer support. Corporates can als ...
This email address is being protected from spambots. You need JavaScript enabled to view it.

For more information:

Make an Inquiry about this report HERE!
  • www.researchbymarkets.com/report/t…18-2022-6297.html
  • www.researchbymarkets.com/paynow/6297
  • www.researchbymarkets.com/inquiry/6297
  • www.researchbymarkets.com